PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

'Programmable' antibiotic harnesses an enzyme to attack drug-resistant microbes

'Programmable' antibiotic harnesses an enzyme to attack drug-resistant microbes
2014-10-05
(Press-News.org) The multitude of microbes scientists have found populating the human body have good, bad and mostly mysterious implications for our health. But when something goes wrong, we defend ourselves with the undiscriminating brute force of traditional antibiotics, which wipe out everything at once, regardless of the consequences.

Researchers at Rockefeller University and their collaborators are working on a smarter antibiotic. And in research to be published October 5 in Nature Biotechnology, the team describes a 'programmable' antibiotic technique that selectively targets the bad bugs, particularly those harboring antibiotic resistance genes, while leaving other, more innocent microbes alone.

"In experiments, we succeeded in instructing a bacterial enzyme, known as Cas9, to target a particular DNA sequence and cut it up," says lead researcher Luciano Marraffini, head of the Laboratory of Bacteriology. "This selective approach leaves the healthy microbial community intact, and our experiments suggest that by doing so you can keep resistance in check and so prevent certain types of secondary infections, eliminating two serious hazards associated with treatment by classical antibiotics."

The new approach could, for instance, reduce the risk of C. diff, a severe infection of the colon, caused by the Clostridium difficile bacterium, that is associated with prolonged courses of harsh antibiotics and is a growing public health concern.

The Cas9 enzyme is part of a defense system that bacteria use to protect themselves against viruses. The team coopted this bacterial version of an immune system, known as a CRISPR (clustered regularly interspaced short palindromic repeats) system and turned it against some of the microbes. CRISPR systems contain unique genetic sequences called spacers that correspond to sequences in viruses. CRISPR-associated enzymes, including Cas9, use these spacer sequences as guides to identify and destroy viral invaders.

The researchers were able to direct Cas9 at targets of their choosing by engineering spacer sequences to match bacterial genes then inserting these sequences into a cell along with the Cas9 gene. The cell's own machinery then turns on the system. Depending on the location of the target in a bacterial cell, Cas9 may kill the cell or it may eradicate the target gene. In some cases, a treatment may prevent a cell from acquiring resistance, they found.

"We previously showed that if Cas9 is programmed with a target from a bacterial genome, it will kill the bacteria. Building on that work, we selected guide sequences that enabled us to selectively kill a particular strain of microbe from within a mixed population," says first author David Bikard, a former Rockefeller postdoc who is now at the Pasteur Institute in Paris.

In initial experiments, Bikard and colleagues targeted a strain of the common skin and respiratory bacteria Staphylococcus aureus that is resistant to the antibiotic kanamycin. Treatment by Cas9 programmed to target a part of the resistance gene killed most of the resistant Staph, but left behind the kanamycin-susceptible Staph.

Targeted bacterial genocide is only one option. Bacteria share genes, including those conferring drug resistance, in the form of rings of DNA known as plasmids. In a second series of experiments, researchers turned Cas9 on tetracycline resistance-harboring plasmids in a strain of the potentially deadly multidrug resistant bacteria Staphylococcus aureus (MRSA). Not only did the resistant cells become sensitive to tetracycline after Cas9 destroyed the plasmids, but the arrival of Cas9 in other Staph cells acted as an immunization, preventing them from taking on resistance-carrying plasmids.

And, in a final set of experiments, conducted in collaboration with Vincent Fischetti's Laboratory of Bacterial Pathogenesis and Immunology, adjunct faculty member Chad Euler confirmed their test tube results on living skin, by using Cas9 to selectively kill kanamycin-resistant Staph infecting the shaved backs of mice.

In spite of the promising results, the delivery system needs improvement. The researchers used bacteria-infecting viruses to inject the programmed Cas9 enzymes into the bacterial cells, but these viruses only attack specific types of cells. Scientists need to devise a less discriminating method of delivery, before the technology can be used to develop a new class of antibiotics, Marraffini says.

In addition to its potential as a much-needed new weapon against drug-resistant microbes, the new system could also be used to advance research on the complex populations of microbes in the body, about which very little is known. "There are enormous microbial communities in the human body," Marraffini says. "Programmable Cas9 enzymes may make it possible to analyze these populations by eliminating their members, one by one, and studying the effects."

INFORMATION:


[Attachments] See images for this press release:
'Programmable' antibiotic harnesses an enzyme to attack drug-resistant microbes

ELSE PRESS RELEASES FROM THIS DATE:

Attacking type 2 diabetes from a new direction with encouraging results

Attacking type 2 diabetes from a new direction with encouraging results
2014-10-05
Type 2 diabetes affects an estimated 28 million Americans according to the American Diabetes Association, but medications now available only treat symptoms, not the root cause of the disease. New research from Rutgers shows promising evidence that a modified form of a different drug, niclosamide – now used to eliminate intestinal parasites – may hold the key to battling the disease at its source. The study, led by Victor Shengkan Jin, an associate professor of pharmacology at Rutgers Robert Wood Johnson Medical School, has been published online by the journal Nature ...

A discovery could prevent the development of brain tumors in children

2014-10-03
Montréal, October 2, 2014 – Scientists at the IRCM discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found that a protein known as Sonic Hedgehog induces DNA damage, which causes the cancer to develop. This important breakthrough will be published in the October 13 issue of the prestigious scientific journal Developmental Cell. The editors also selected the article to be featured on the journal's cover. Sonic Hedgehog belongs to a family of proteins that gives ...

LGBT bioethics: Visibility, disparities, and dialogue

2014-10-03
Despite the legalization of same-sex marriage in 19 states and the District of Columbia and an executive order to prohibit federal contractors from discrimination against lesbian, gay, bisexual, and transgender employees, LGBT individuals face tremendous hurdles in access to health care and basic human rights. A special report published by The Hastings Center, LGBT Bioethics: Visibility, Disparities, and Dialogue, is a call to action for the bioethics field to help right the wrongs in the ways that law, medicine, and society have treated LGBT people. The editors are Tia ...

New study finds lack of adherence to safe handling guidelines for administration of antineoplastic drugs

2014-10-03
FALLS CHURCH, Va. (October 3, 2014) — A new National Institute for Occupational Safety and Health (NIOSH) study, published online in the Journal of Occupational and Environmental Hygiene, found that recommended safe handling practices for workers who administer antineoplastic drugs in healthcare settings are not always followed. Results are derived from the 2011 Health and Safety Practices Survey of Healthcare Workers, the largest federally-sponsored survey of healthcare workers in the U.S., which addresses safety and health practices relative to use of hazardous chemicals. ...

Alcohol consumption associated with increased risk of HPV infection in men, say Moffitt researchers

2014-10-03
Men who consume more alcohol have a greater risk of human papillomavirus (HPV) infection, according to a recent study by Moffitt Cancer Center researchers. HPV is a common sexually transmitted virus, with more than six million new infections in the United States each year. HPV causes genital warts in both men and women and is a contributing factor to a number of different cancers in women, including cervical, vaginal and anal cancers. More recent studies have shown that HPV can also cause penile, anal and oropharyngeal cancer in men. However, there is limited data regarding ...

NASA's SDO watches giant filament on the sun

NASAs SDO watches giant filament on the sun
2014-10-03
A snaking, extended filament of solar material currently lies on the front of the sun-- some 1 million miles across from end to end. Filaments are clouds of solar material suspended above the sun by powerful magnetic forces. Though notoriously unstable, filaments can last for days or even weeks. NASA's Solar Dynamics Observatory, or SDO, which watches the sun 24 hours a day, has observed this gigantic filament for several days as it rotated around with the sun. If straightened out, the filament would reach almost across the whole sun, about 1 million miles or 100 times ...

Study questions the prescription for drug resistance

2014-10-03
In response to the rise of drug-resistant pathogens, doctors are routinely cautioned against overprescribing antimicrobials. But when a patient has a confirmed bacterial infection, the advice is to treat aggressively to quash the infection before the bacteria can develop resistance. A new study questions the accepted wisdom that aggressive treatment with high drug dosages and long durations is always the best way to stem the emergence and spread of resistant pathogens. The review of nearly 70 studies of antimicrobial resistance, which was authored by researchers at Princeton ...

Two NASA satellites stare at Typhoon Phanfone's large eye

Two NASA satellites stare at Typhoon Phanfones large eye
2014-10-03
Two NASA satellites captured data on Typhoon Phanfone as it continues to strengthen as it moves through the Northwestern Pacific Ocean. The Tropical Rainfall Measuring Mission or TRMM satellite flew over Typhoon Phanfone on Oct. 2, 2014 at 0939 UTC (5:39 a.m. EDT). The rainfall pattern observed using TRMM's Microwave Imager (TMI) and Precipitation Radar (PR) data showed that Phanfone was much better organized than a day earlier. This precipitation analysis revealed that intensifying typhoon Phanfone had formed a large eye. The heaviest rainfall was shown falling at a ...

NASA's Terra satellite sees birth of Tropical Storm Vongfong in Western Pacific

NASAs Terra satellite sees birth of Tropical Storm Vongfong in Western Pacific
2014-10-03
NASA's Terra satellite spotted the birth of Tropical Storm Vongfong in the Northwestern Pacific Ocean on Oct. 3. Vongfong is the nineteenth tropical storm of the Northwestern Pacific typhoon season. The MODIS or Moderate Resolution Imaging Spectroradiometer instrument that flies aboard NASA's Terra satellite captured a visible image of Tropical Storm Vongfong on Oct. 3 at 00:30 UTC (Oct. 2 at 8:30 p.m. EDT). At the time of the image, the center of Tropical Storm Vongfong was located just to the northeast of Pohnpei, one of four states in the Federated States of Micronesia. ...

Satellite sees Tropical Storm Simon crawling up Western Mexico's coastline

Satellite sees Tropical Storm Simon crawling up Western Mexicos coastline
2014-10-03
Tropical Storm Simon is following the path of several other tropical storms that formed in the Eastern Pacific Ocean by crawling northward along the western coastline of Mexico. NOAA's GOES-West satellite captured an infrared image of Simon on Oct. 3 that showed the eastern side of the storm over Mexico. An infrared image taken from NOAA's GOES-West satellite on Oct .3 at 7:45 a.m. EDT showed strong thunderstorms circling Tropical Storm Simon's center and a fragmented band of thunderstorms in Simon's eastern quadrant bringing rainfall to western Mexico. Simon's center ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] 'Programmable' antibiotic harnesses an enzyme to attack drug-resistant microbes